Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis
โ Scribed by A. H. Siddiqui; L. Stolk; H. R. Korthals Altes-Levij van Vinninghe; A. Kammeijer; R. H. Cormane
- Publisher
- Springer-Verlag
- Year
- 1982
- Tongue
- English
- Weight
- 263 KB
- Volume
- 273-273
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A method based on a combination of cell culture and pharmacokinetic data is explored as a way of estimating the possible genetic risk to man from a mutagenic chemical. 8-methoxypsoralen, which is given to psoriasis patients as part of a photochemotherapy regime, is used, since it represents a 'real-
A method is described for the determination of 8-methoxypsoralen in human serum using a fluorodensitometric method. The fluorescence densitometry was carried out directly on the thin layer plate. The developing fluid consisted of chloroform/methanol. In patients with psoriasis after oral application
Lymphocyte-transformation by phytohaemagglutinine (PHA) was examined in 21 patients with generalized psoriasis during photochemotherapy (PUVA). Lymphocyte-transformation-tests (LTT) were performed before and after 8-methoxypsoralen (8-MOP) medication, before and after the initial irradiation and bef
T-lymphocyte count in the peripheral blood, based on the identification of anti-human lymphocyte antigen (HTLA) by an immunocytochemical method, was determined in 25 PUVA-treated psoriatics and in 25 controls matched by sex and age. The results demonstrate that the HTLA-positive lymphocyte counts o